Document is current
Any future updates will be listed below
-
Authors
Hochhaus, Andreas
Gale, Robert Peter
- License Information
-
More Information
Article History
First Online: 8 December 2025
Competing interests
: RPG is a consultant to Antengene Biotech LLC; Medical Director, FFF Enterprises Inc.; A speaker for Janssen Pharma and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd. AH received research support by Novartis, BMS, Incyte, Pfizer, TERNS, and Enliven Pharma, RPG and AH are Editors-in-Chief of Leukemia.
